(19)
(11) EP 1 207 855 A1

(12)

(43) Date of publication:
29.05.2002 Bulletin 2002/22

(21) Application number: 00956670.4

(22) Date of filing: 25.08.2000
(51) International Patent Classification (IPC)7A61K 9/16, A61K 31/12, A61P 29/00, A61P 19/02
(86) International application number:
PCT/GB0003/312
(87) International publication number:
WO 0113/889 (01.03.2001 Gazette 2001/09)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 25.08.1999 GB 9920148

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford,Middlesex TW8 9EP (GB)

(72) Inventor:
  • CUMMINGS, Paul John,SmithKline Beecham Pharmac
    Harlow,Essex CM19 5AW (GB)

(74) Representative: Rutter, Keith et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING NABUMETONE